Candriam Equities L Oncology Impact, N - Capitalisation
LU2346866317
Candriam Equities L Oncology Impact, N - Capitalisation/ LU2346866317 /
NAV 07.06.2024
Diff.+0,7500
Ertragstyp
Ausrichtung
Fondsgesellschaft
158,3700 EUR
+0,48%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in EUR
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.399,0500
+8,63%
+4,84%
Candriam Equities L Oncology Imp...
thesaurierend
2.563,7100
+8,77%
+5,23%
Candriam Equities L Oncology Imp...
thesaurierend
207,4400
+5,05%
-6,00%
Candriam Equities L Oncology Imp...
thesaurierend
2.240,9199
+6,07%
+15,66%
Candriam Equities L Oncology Imp...
ausschüttend
1.609,7500
+8,28%
+3,83%
Candriam Equities L Oncology Imp...
thesaurierend
246,3900
+6,23%
+13,78%
Candriam Equities L Oncology Imp...
ausschüttend
235,9300
+7,27%
+0,96%
Candriam Equities L Oncology Imp...
ausschüttend
191,1300
+8,19%
+3,53%
Candriam Equities L Oncology Imp...
ausschüttend
20.700,0000
+3,50%
+0,87%
Candriam Equities L Oncology Imp...
thesaurierend
158,5300
+5,95%
+15,27%
Candriam Equities L Oncology Imp...
thesaurierend
2.110,1499
+6,05%
-3,31%
Candriam Equities L Oncology Imp...
thesaurierend
261,1800
+7,13%
+16,69%
Candriam Equities L Oncology Imp...
thesaurierend
206,8800
+4,63%
-7,11%
Candriam Equities L Oncology Imp...
thesaurierend
286,5900
+8,17%
+3,52%
Candriam Equities L Oncology Imp...
thesaurierend
193,8000
+5,93%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.848,6700
+6,41%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.885,3501
+7,84%
+3,98%
Candriam Equities L Oncology Imp...
thesaurierend
158,3700
-
-
Candriam Equities L Oncology Imp...
thesaurierend
274,5000
+6,83%
+1,09%
Performance
lfd. Jahr
-
6 Monate
-
1 Jahr
-
3 Jahre
-
5 Jahre
-
10 Jahre
-
seit Beginn
+3,82%
Jahr